tiprankstipranks
Trending News
More News >
Candel Therapeutics (CADL)
NASDAQ:CADL
US Market

Candel Therapeutics (CADL) Income Statement

Compare
413 Followers

Candel Therapeutics Income Statement

Last quarter (Q3 2025), Candel Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Candel Therapeutics's net income was $-11.27M. See Candel Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 125.00K$ 125.00K$ 125.00K
Gross Profit
$ -990.00K$ -23.98M$ 125.00K$ -14.47M$ 125.00K
Operating Expenses
$ 32.38M$ 14.41M$ 34.85M$ 11.26M$ 13.94M
Depreciation and Amortization
$ 990.00K$ 960.00K$ 778.00K$ 232.00K$ 91.00K
EBITDA
$ -52.10M$ -37.43M$ -16.31M$ -25.49M$ -13.72M
Operating Income
$ -33.37M$ -38.39M$ -34.72M$ -25.73M$ -13.81M
Other Income/Expenses
$ -21.81M$ 452.00K$ 15.93M$ -10.40M$ -3.87M
Pretax Income
$ -55.18M$ -37.94M$ -18.79M$ -36.12M$ -17.68M
Net Income
$ -55.18M$ -37.94M$ -18.79M$ -36.12M$ -17.68M
Per Share Metrics
Basic EPS
$ -1.74$ -1.31$ -0.10$ -1.26$ -1.18
Diluted EPS
$ -1.74$ -1.31$ -0.10$ -1.26$ -1.18
Weighted Average Shares Outstanding
31.68M 28.94M 28.82M 28.69M 18.71M
Weighted Average Shares Outstanding (Diluted)
31.68M 28.94M 28.82M 28.69M 18.71M
Currency in USD

Candel Therapeutics Earnings and Revenue History